|
Re: Chinese Proverbs
|
3
|
Resverlogix Corp.
|
Jan 31, 2016 07:34PM
|
|
Re: Chinese Takeovers
|
|
Zenith Epigenetics
|
Mar 07, 2018 03:56PM
|
|
Re: Chinese Takeovers
|
2
|
Zenith Epigenetics
|
Mar 08, 2018 11:53AM
|
|
Re: Chinese Takeovers
|
1
|
Zenith Epigenetics
|
Mar 07, 2018 10:49AM
|
|
Re: Citigroup note on Epigenetics - a big initiation note published on 22 October
|
4
|
Resverlogix Corp.
|
Oct 27, 2015 12:35PM
|
|
Re: Clarification on BETonMACE baseline data
|
4
|
Resverlogix Corp.
|
Sep 09, 2019 05:18PM
|
|
Re: Classifying/taxonomy mCRPC patients
|
2
|
Zenith Epigenetics
|
May 01, 2019 03:27PM
|
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
2
|
Resverlogix Corp.
|
Nov 06, 2021 11:49AM
|
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
2
|
Resverlogix Corp.
|
Nov 04, 2021 06:01PM
|
|
Re: Compensation Commity
|
5
|
Resverlogix Corp.
|
Mar 28, 2021 12:13PM
|
|
Re: Compounds and Autoimmune
|
3
|
Resverlogix Corp.
|
Jun 21, 2016 05:23PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 12:25PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
5
|
Resverlogix Corp.
|
Jun 02, 2022 02:44PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 03:29PM
|
|
Re: Confused
|
2
|
Zenith Epigenetics
|
Dec 20, 2015 10:53AM
|
|
Re: Confused
|
2
|
Zenith Epigenetics
|
Dec 19, 2015 11:06AM
|
|
Re: Congrats
|
1
|
Resverlogix Corp.
|
Jul 25, 2017 12:42PM
|
|
Re: Consequences of BETonMACE Findings
|
5
|
Resverlogix Corp.
|
May 11, 2016 03:50PM
|
|
Re: Consequences of BETonMACE Findings
|
3
|
Resverlogix Corp.
|
May 10, 2016 04:07PM
|
|
Re: Conspiracies of sorts
|
4
|
Resverlogix Corp.
|
Sep 28, 2015 10:52AM
|
